Search

everythinglearnresearchcommunity

for

Search:↓

Avoid high-tension styles and use professional treatments to reduce hair damage and health risks.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Chronic stress and high cortisol levels can cause hair loss by disrupting hair growth.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Sleep patterns might be linked to hair loss, but more research is needed.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Early and accurate identification of primary scarring alopecias is crucial to prevent permanent hair loss.

UVF-dermoscopy is a useful tool for accurately diagnosing types of alopecia, especially in people with lighter skin.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.